Strides Pharma Science on Monday said the European Medicines Agency has recommended granting market authorisation for Kauliv, an injection intended for the treatment of osteoporosis, developed by its biologics arm Stelis Biopharma.
About the Author
Strides Pharma Science on Monday said the European Medicines Agency has recommended granting market authorisation for Kauliv, an injection intended for the treatment of osteoporosis, developed by its biologics arm Stelis Biopharma.
